We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
Cap. Flow
+$1.9B
Cap. Flow %
2.12%
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$60.1M
2
TSM icon
TSMC
TSM
+$59.1M
3
TSLA icon
Tesla
TSLA
+$56M
4
AAPL icon
Apple
AAPL
+$55.2M
5
AMZN icon
Amazon
AMZN
+$47.5M

Top Sells

Rank Stock Value
1
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$102M
2
EG icon
Everest Group
EG
+$27.4M
3
CVX icon
Chevron
CVX
+$25M
4
WFC icon
Wells Fargo
WFC
+$24.9M
5
CXT icon
Crane NXT
CXT
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 27.27%
2 Healthcare 12.98%
3 Financials 12.17%
4 Consumer Discretionary 11.18%
5 Industrials 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIP
3726
DELISTED
ATI Physical Therapy, Inc.
ATIP
$4.11K ﹤0.01%
449
-1,739
-79% -$19.8K
XHG
3727
XChange TEC
XHG
$3.96K ﹤0.01%
+1
New +$9K
CMMB
3728
Chemomab Therapeutics
CMMB
$13.2M
$3.94K ﹤0.01%
+751
New +$4.74K
GAIA icon
3729
Gaia
GAIA
$48.1M
$3.93K ﹤0.01%
+1,700
New +$4.72K
ZEPP
3730
Zepp Health
ZEPP
$68.2M
$3.86K ﹤0.01%
+848
New +$4.28K
HYFM icon
3731
Hydrofarm Holdings
HYFM
$8.77M
$3.85K ﹤0.01%
493
-5,950
-92% -$71.1K
WGS icon
3732
GeneDx Holdings
WGS
$2.08B
$3.83K ﹤0.01%
643
-10,399
-94% -$82.3K
NA
3733
Nano Labs
NA
$42.5M
$3.76K ﹤0.01%
+191
New +$3.03K
LOCL icon
3734
Local Bounti
LOCL
$22.3M
$3.75K ﹤0.01%
1,380
-2,246
-62% -$12.8K
DNK
3735
DELISTED
Phoenix Tree Holdings Limited American Depositary Shares, each representing ten (10) Class A ordinar
DNK
$3.74K ﹤0.01%
+1,580
New +$3.74K
EXK
3736
Endeavour Silver
EXK
$2.61B
$3.7K ﹤0.01%
+1,282
New +$4.53K
EARN
3737
Ellington Residential Mortgage REIT
EARN
$163M
$3.7K ﹤0.01%
+513
New +$3.65K
HLTH
3738
DELISTED
Cue Health Inc. Common Stock
HLTH
$3.69K ﹤0.01%
10,006
-157,275
-94% -$134K
RDHL
3739
Redhill Biopharma
RDHL
$3.53M
$3.65K ﹤0.01%
+121
New +$6.97K
CYAD
3740
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$3.6K ﹤0.01%
+9,000
New +$6.36K
ATER icon
3741
Aterian
ATER
$5.02M
$3.6K ﹤0.01%
652
-7,674
-92% -$59.7K
NNBR icon
3742
NN Inc
NNBR
$298M
$3.57K ﹤0.01%
+1,495
New +$2.26K
DRRX
3743
DELISTED
DURECT Corp
DRRX
$3.51K ﹤0.01%
+710
New +$3.6K
QH
3744
Quhuo Limited Class A Ordinary Shares
QH
$12.5M
$3.51K ﹤0.01%
+19
New +$3.22K
ACR
3745
ACRES Commercial Realty
ACR
$104M
$3.46K ﹤0.01%
+392
New +$3.4K
SPPI
3746
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3.46K ﹤0.01%
+3,600
New +$3.56K
EIGR
3747
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.44K ﹤0.01%
163
-1,686
-91% -$51.9K
OTLY
3748
Oatly Group
OTLY
$437M
$3.42K ﹤0.01%
+84
New +$3.43K
SDC
3749
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$3.4K ﹤0.01%
+6,425
New +$2.62K
VJET
3750
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$3.35K ﹤0.01%
+1,945
New +$3.76K

Similar funds

RhumbLine Advisers's Q2 2023 Portfolio in Review

As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
  • RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
  • RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
  • RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
  • RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.

Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.